Sabrina Popatia
Dermatology · Brooklyn, NYNPI 1780248948
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 29.1% of the total. 2025 is the largest year on record at $1,841, more than ten times the $112 reported in 2023. That places this record below the midpoint for dermatology clinicians in NY, where the typical reported total is $2,360.
Across 124 payments — averaging $21.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$787
- Incyte Corporation$313
- Novartis$249
- Johnson & Johnson$226
- UCB, Inc.$168
- Arcutis Biotherapeutics, Inc.$151
- plus $814 from 12 others
What the payments were for
- Food & beverage$2,707100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $787 |
| Incyte Corporation | 14 | $313 |
| Novartis | 10 | $249 |
| Johnson & Johnson | 12 | $226 |
| UCB, Inc. | 7 | $168 |
| Arcutis Biotherapeutics, Inc. | 8 | $151 |
| Mayne Pharma Commercial LLC | 7 | $143 |
| Sanofi | 4 | $137 |
| Lilly USA, LLC | 7 | $131 |
| Fresenius Kabi USA, LLC | 5 | $112 |
| Sun Pharmaceutical Industries Inc. | 4 | $106 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
| Journey Medical Corporation | 2 | $31 |
| Merck | 1 | $31 |
| Galderma Laboratories, L.p. | 1 | $25 |
| Cipher Pharmaceuticals US LLC | 1 | $21 |
| Pfizer | 1 | $17 |
| LEO Pharma Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,707 in reported general payments places this provider in the 50th percentile of 1,151 dermatology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 11 | $221,061 |
| Clobetasol Propionate | 90 | $3,934 |
| Triamcinolone Acetonide | 57 | $1,067 |
| Dapsone | 12 | $602 |
| Ketoconazole | 46 | $504 |
| Clindamycin Phosphate | 23 | $417 |
| Doxycycline Hyclate | 13 | $177 |
| Minoxidil | 12 | $149 |
| Hydrocortisone | 30 | $136 |
| MethotrexateMethotrexate Sodium | 12 | $97 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Brooklyn
- Hilary BaldwinBrooklyn$1.5M
- Steven BaranowitzBrooklyn$625K
- Susan BardBrooklyn$425K
- Nanette SilverbergBrooklyn$337K
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Jeffrey WeinbergKew Gardens$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.